miR-23a-3p is involved in drug resistance by directly targeting the influx drug transporter organic anion-transporting polypeptide 2

被引:0
|
作者
Yi Guo
Junzhi Li
Yu Kang
Li Jiang
机构
[1] Ministry of Education Key Laboratory of Child Development and Disorders,Department of Neurology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders
[2] Chongqing Key Laboratory of Pediatrics,Department of Cardiovascular Disease, School of Medicine
[3] Chongqing Medical University,undefined
[4] Shanghai Jiaotong University,undefined
来源
Child's Nervous System | 2021年 / 37卷
关键词
MicroRNA; miR-23a-3p; Drug transporter; Organic anion-transporting polypeptide 2; Valproate; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2545 / 2555
页数:10
相关论文
共 50 条
  • [1] miR-23a-3p is involved in drug resistance by directly targeting the influx drug transporter organic anion-transporting polypeptide 2
    Guo, Yi
    Li, Junzhi
    Kang, Yu
    Jiang, Li
    CHILDS NERVOUS SYSTEM, 2021, 37 (08) : 2545 - 2555
  • [2] Organic anion-transporting polypeptide (OATP) transporter family and drug disposition
    Kim, RB
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 1 - 5
  • [3] CHARACTERIZATION OF A NOVEL TRANSPORTER MODEL FOR STUDYING DRUG INTERACTION WITH ORGANIC ANION-TRANSPORTING POLYPEPTIDE (OATP)
    Li, Na
    Wang, Jie
    Cooper, Kirsten
    Bourgea, Joanne
    Crespi, Charles L.
    Patten, Christopher J.
    DRUG METABOLISM REVIEWS, 2014, 45 : 252 - 252
  • [4] The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions
    DuBuske, LM
    DRUG SAFETY, 2005, 28 (09) : 789 - 801
  • [5] The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions
    Lawrence M. DuBuske
    Drug Safety, 2005, 28 : 789 - 801
  • [6] P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug-herb/drug-drug interactions
    Liang, Sheng
    Deng, Fengchun
    Xing, Haiyan
    Wen, He
    Shi, Xiaoyan
    Martey, Orleans Nii
    Koomson, Emmanuel
    He, Xin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 475 - 483
  • [7] Disposition Pathway-Dependent Approach for Predicting Organic Anion-Transporting Polypeptide-Mediated Drug–Drug Interactions
    Zhe-Yi Hu
    Clinical Pharmacokinetics, 2013, 52 : 433 - 441
  • [8] Disposition Pathway-Dependent Approach for Predicting Organic Anion-Transporting Polypeptide-Mediated Drug-Drug Interactions
    Hu, Zhe-Yi
    CLINICAL PHARMACOKINETICS, 2013, 52 (06) : 433 - 441
  • [9] Genetic Polymorphisms and Function of the Organic Anion-Transporting Polypeptide 1A2 and Its Clinical Relevance in Drug Disposition
    Zhou, Yinhui
    Yuan, Jingjing
    Li, Zhisong
    Wang, Zhongyu
    Cheng, Dan
    Du, Yingying
    Li, Wenlu
    Kan, Quancheng
    Zhang, Wei
    PHARMACOLOGY, 2015, 95 (3-4) : 201 - 208
  • [10] Scutellarin is Highly Likely to be Responsible for Drug-Drug Interactions Mediated by Hepatic Organic Anion-Transporting Polypeptide1B3
    Liu, Jianming
    Guo, Yongmei
    Xu, Yanqi
    Yuan, Li
    Zhu, Huiting
    PHARMACEUTICAL RESEARCH, 2020, 37 (12)